These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30315883)

  • 1. Role of RACK1 on cell proliferation, adhesion, and bortezomib-induced apoptosis in multiple myeloma.
    Zhang L; Xu Y; Wang L; Liu H
    Int J Biol Macromol; 2019 Jan; 121():1077-1085. PubMed ID: 30315883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RACK1 targets the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to link integrin engagement with focal adhesion disassembly and cell motility.
    Vomastek T; Iwanicki MP; Schaeffer HJ; Tarcsafalvi A; Parsons JT; Weber MJ
    Mol Cell Biol; 2007 Dec; 27(23):8296-305. PubMed ID: 17908799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib could down-regulate the expression of RANKL, inhibit cell proliferation and induce cell apoptosis in the human myeloma cell line RPMI 8226 by activating casepase-3.
    Lin L; Chen D; Xiang ZF; Pei RZ; Zhang PS; Liu XH; Du XH; Lu Y
    Cancer Biomark; 2017 Aug; 20(2):217-224. PubMed ID: 28869453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression.
    De Smedt E; Maes K; Verhulst S; Lui H; Kassambara A; Maes A; Robert N; Heirman C; Cakana A; Hose D; Breckpot K; van Grunsven LA; De Veirman K; Menu E; Vanderkerken K; Moreaux J; De Bruyne E
    Cancer Res; 2018 Mar; 78(5):1155-1168. PubMed ID: 29259009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of DTX3L on the cell proliferation, adhesion, and drug resistance of multiple myeloma cells.
    Shen Y; Sun Y; Zhang L; Liu H
    Tumour Biol; 2017 Jun; 39(6):1010428317703941. PubMed ID: 28653881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of the thyroid hormones-αvβ3 pathway in primary myeloma bone marrow cells and to bortezomib action.
    Cohen K; Ellis M; Shinderman E; Khoury S; Davis PJ; Hercbergs A; Ashur-Fabian O
    Leuk Lymphoma; 2015 Apr; 56(4):1107-14. PubMed ID: 25058375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells.
    Chen G; Xu Z; Chang G; Hou J; Hu L; Zhang Y; Yu D; Li B; Chang S; Xie Y; Zhang Y; Wei R; Wu H; Xiao W; Sun X; Tao Y; Gao L; Dai B; Shi J; Zhu W
    Oncol Rep; 2017 Jul; 38(1):488-496. PubMed ID: 28560392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USO1 promotes tumor progression via activating Erk pathway in multiple myeloma cells.
    Jin Y; Dai Z
    Biomed Pharmacother; 2016 Mar; 78():264-271. PubMed ID: 26898451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
    Que W; Chen J; Chuang M; Jiang D
    APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBQ3 participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
    Liu H; Ding L; Shen Y; Zhong F; Wang Q; Xu X
    Int J Biol Macromol; 2016 Oct; 91():115-22. PubMed ID: 27189701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L.
    Liu H; Guo D; Sha Y; Zhang C; Jiang Y; Hong L; Zhang J; Jiang Y; Lu L; Huang H
    Aging (Albany NY); 2020 Jun; 12(11):11100-11115. PubMed ID: 32526706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance.
    Yao Y; Xia D; Bian Y; Sun Y; Zhu F; Pan B; Niu M; Zhao K; Wu Q; Qiao J; Fu C; Li Z; Xu K
    Apoptosis; 2015 Aug; 20(8):1122-33. PubMed ID: 26033479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib induces apoptosis and autophagy in osteosarcoma cells through mitogen-activated protein kinase pathway in vitro.
    Lou Z; Ren T; Peng X; Sun Y; Jiao G; Lu Q; Zhang S; Lu X; Guo W
    J Int Med Res; 2013 Oct; 41(5):1505-19. PubMed ID: 23975859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RACK1 cooperates with NRAS
    Campagne C; Reyes-Gomez E; Picco ME; Loiodice S; Salaun P; Ezagal J; Bernex F; Commère PH; Pons S; Esquerre D; Bourneuf E; Estellé J; Maskos U; Lopez-Bergami P; Aubin-Houzelstein G; Panthier JJ; Egidy G
    Cell Signal; 2017 Aug; 36():255-266. PubMed ID: 28343944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network-Based Analysis of Bortezomib Pharmacodynamic Heterogeneity in Multiple Myeloma Cells.
    Ramakrishnan V; Mager DE
    J Pharmacol Exp Ther; 2018 Jun; 365(3):734-751. PubMed ID: 29632237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphA4 promotes cell proliferation and cell adhesion-mediated drug resistance via the AKT pathway in multiple myeloma.
    Ding L; Shen Y; Ni J; Ou Y; Ou Y; Liu H
    Tumour Biol; 2017 Mar; 39(3):1010428317694298. PubMed ID: 28351297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,5-Dihydroxyacetophenone Induces Apoptosis of Multiple Myeloma Cells by Regulating the MAPK Activation Pathway.
    Ko JH; Lee JH; Jung SH; Lee SG; Chinnathambi A; Alharbi SA; Yang WM; Um JY; Sethi G; Ahn KS
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28696369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin suppresses the proliferation of multiple myeloma cells by down-regulating IQ motif-containing GTPase activating protein 1 expression and extracellular signal-regulated kinase activation.
    Ma Y; Jin Z; Huang J; Zhou S; Ye H; Jiang S; Yu K
    Leuk Lymphoma; 2014 Nov; 55(11):2597-604. PubMed ID: 24397597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment.
    Gu C; Feng L; Peng H; Yang H; Feng Z; Yang Y
    Oncotarget; 2016 Jan; 7(4):4559-69. PubMed ID: 26683226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.